Yaz is the first oral contraceptive approved for premenstrual dysphoric disorder (PMDD)
November 2006
Yaz is the first oral contraceptive approved for premenstrual dysphoric disorder (PMDD).
About 5% of reproductive age women have this more severe form of premenstrual syndrome.
Yaz seems to help both physical AND emotional symptoms.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote